Year |
Citation |
Score |
2020 |
Hegde S, Krisnawan VE, Herzog BH, Zuo C, Breden MA, Knolhoff BL, Hogg GD, Tang JP, Baer JM, Mpoy C, Lee KB, Alexander KA, Rogers BE, Murphy KM, Hawkins WG, ... ... DeSelm CJ, et al. Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer. Cancer Cell. 37: 289-307.e9. PMID 32183949 DOI: 10.1016/J.Ccell.2020.02.008 |
0.328 |
|
2020 |
Imber BS, Sadelain M, DeSelm C, Batlevi C, Brentjens RJ, Dahi PB, Giralt S, Park JH, Sauter C, Scordo M, Shah G, Perales MA, Palomba ML, Yahalom J. Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy. British Journal of Haematology. PMID 32135029 DOI: 10.1111/Bjh.16541 |
0.325 |
|
2019 |
Xu AJ, DeSelm CJ, Ho AY, Gillespie EF, Braunstein LZ, Khan AJ, McCormick B, Powell SN, Cahlon O. Overall Survival of Breast Cancer Patients With Locoregional Failures Involving Internal Mammary Nodes. Advances in Radiation Oncology. 4: 447-452. PMID 31360798 DOI: 10.1016/J.Adro.2019.02.004 |
0.312 |
|
2019 |
Imber B, Palomba ML, DeSelm C, Batlevi CL, Dahi PB, Giralt SA, Noy A, Park JH, Sauter CS, Scordo M, Shah GL, Sadelain M, Perales M, Yahalom J. MSKCC Early Experience Using Radiotherapy As a Bridging Strategy for Relapsed Diffuse Large B Cell Lymphoma before CD19 CAR T Therapy Blood. 134: 3238-3238. DOI: 10.1182/Blood-2019-131449 |
0.301 |
|
2019 |
Imber B, Palomba ML, DeSelm C, Dahi PB, Sauter CS, Scordo M, Batlevi CL, Park JH, Shah GL, Giralt SA, Perales M, Sadelain M, Yahalom J. Early Experience Using Radiotherapy As a Salvage Treatment for Relapsed or Refractory Non-Hodgkin Lymphomas Following CD19 Chimeric Antigen Receptor Modified T-Cell Therapy Blood. 134: 3244-3244. DOI: 10.1182/Blood-2019-129620 |
0.308 |
|
2018 |
DeSelm C, Palomba ML, Yahalom J, Hamieh M, Eyquem J, Rajasekhar VK, Sadelain M. Low-Dose Radiation Conditioning Enables CAR T Cells to Mitigate Antigen Escape. Molecular Therapy : the Journal of the American Society of Gene Therapy. 26: 2542-2552. PMID 30415658 DOI: 10.1016/J.Ymthe.2018.09.008 |
0.337 |
|
2018 |
DeSelm C, Yang TJ, Cahlon O, Tisnado J, Khan AJ, Gillespie EF, Siu CT, Powell SN, Ho AY. A 3-Dimensional Mapping Analysis of Regional Nodal Recurrences in Breast Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 30367906 DOI: 10.1016/J.Ijrobp.2018.10.021 |
0.326 |
|
2017 |
DeSelm CJ, Tano ZE, Varghese AM, Adusumilli PS. CAR T-cell therapy for pancreatic cancer. Journal of Surgical Oncology. PMID 28346697 DOI: 10.1002/Jso.24627 |
0.347 |
|
2016 |
Xu AJ, DeSelm CJ, Ho AY, McCormick B, Powell SN, Cahlon O. Overall Survival of Breast Cancer Patients With Recurrent Disease Involving Internal Mammary Nodes. International Journal of Radiation Oncology, Biology, Physics. 96: E34. PMID 27674423 DOI: 10.1016/J.Ijrobp.2016.06.677 |
0.31 |
|
2016 |
Romesser PB, Cahlon O, Scher ED, Hug EB, Sine K, DeSelm C, Fox JL, Mah D, Garg MK, Han-Chih Chang J, Lee NY. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes. International Journal of Radiation Oncology, Biology, Physics. 95: 386-95. PMID 27084656 DOI: 10.1016/J.Ijrobp.2016.02.036 |
0.332 |
|
2016 |
Lok BH, Zong J, Gutinov SI, Cai X, Deselm C, Romesser PB, Lanning RM, Shcherba M, Xiao H, Sherman EJ, Tsai CJ, Riaz N, McBride SM, Cahlon O, Lee NY. Proton radiotherapy for incurable recurrent or metastatic cancers of the head and neck by the RTOG 8502 hypofractionated palliative schedule. Journal of Clinical Oncology. 34. DOI: 10.1200/Jco.2016.34.15_Suppl.E21699 |
0.323 |
|
2016 |
DeSelm C, Hamieh M, Sadelain M. Radiation Sensitizes Tumor Cells to CAR T Cell Immunotherapy International Journal of Radiation Oncology*Biology*Physics. 96: S127. DOI: 10.1016/J.Ijrobp.2016.06.310 |
0.31 |
|
2015 |
Kramer K, Pandit-Taskar N, Zanzonico P, Wolden SL, Humm JL, DeSelm C, Souweidane MM, Lewis JS, Cheung NK. Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy. Journal of Neuro-Oncology. 123: 245-9. PMID 25944385 DOI: 10.1007/S11060-015-1788-Z |
0.311 |
|
2012 |
Rashmi R, DeSelm C, Schwarz JK. Abstract 2279: Akt inhibitor SC-66 leads to inhibition of mTOR pathway in cervical cancer cell line C33A. Cancer Research. 72: 2279-2279. DOI: 10.1158/1538-7445.Am2012-2279 |
0.318 |
|
Show low-probability matches. |